Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Cabanillas

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
The Lancet. Oncology|September 24, 2011
Rituximab in DLBCL: 6 years onFernando Cabanillas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2013
Reply to I.E. HainesFernando Cabanillas
Clinical Lymphoma|January 11, 2003
Metabolic abnormalities in lymphomaFernando Cabanillas
Puerto Rico Health Sciences Journal|August 31, 2010
Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later?Fernando Cabanillas
Current Opinion in Oncology|September 3, 2010
Front-line management of diffuse large B cell lymphomaFernando Cabanillas
The Lancet. Oncology|October 26, 2010
How important is whole brain radiotherapy for treatment of primary CNS lymphoma?Fernando Cabanillas
Leukemia & Lymphoma|May 10, 2007
Dose dense CHOP: when more is not always better!Fernando Cabanillas
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Non-Hodgkin's lymphoma: the old and the newFernando Cabanillas
Hematology (Amsterdam, Netherlands)|April 18, 2012
New developments in the field of diffuse large cell lymphomaFernando Cabanillas
The Lancet. Oncology|June 2, 2012
Pixantrone: a new agent for relapsed aggressive lymphomasFernando Cabanillas
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
The Lancet. Oncology|September 24, 2011
Rituximab in DLBCL: 6 years onFernando Cabanillas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2013
Reply to I.E. HainesFernando Cabanillas
Clinical Lymphoma|January 11, 2003
Metabolic abnormalities in lymphomaFernando Cabanillas
Puerto Rico Health Sciences Journal|August 31, 2010
Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later?Fernando Cabanillas
Current Opinion in Oncology|September 3, 2010
Front-line management of diffuse large B cell lymphomaFernando Cabanillas
The Lancet. Oncology|October 26, 2010
How important is whole brain radiotherapy for treatment of primary CNS lymphoma?Fernando Cabanillas
Leukemia & Lymphoma|May 10, 2007
Dose dense CHOP: when more is not always better!Fernando Cabanillas
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Non-Hodgkin's lymphoma: the old and the newFernando Cabanillas
Hematology (Amsterdam, Netherlands)|April 18, 2012
New developments in the field of diffuse large cell lymphomaFernando Cabanillas
The Lancet. Oncology|June 2, 2012
Pixantrone: a new agent for relapsed aggressive lymphomasFernando Cabanillas
Pageof 11